Wai Chun Bio Technology Revises Capital Reorganisation Timetable
Wai Chun Bio-Technology Limited has announced a revised timetable for its proposed capital reorganisation and a connected transaction involving alterations to the terms of its existing convertible bonds. The company had expected the capital reorganisation to take effect and dealings in the new ordinary shares to commence at 9:00 a.m. on 28 October 2025, pending registration formalities in the Cayman Islands. However, while the Grand Court has granted an order confirming the capital reduction, additional time is required for registration. Shareholders and potential investors are advised to exercise caution, as completion of the related subscription agreement is still subject to certain conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Chun Bio Technology Ltd. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。